Chemed Corporation
CHE · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,431,287 | $2,264,417 | $2,134,963 | $2,139,261 |
| % Growth | 7.4% | 6.1% | -0.2% | – |
| Cost of Goods Sold | $1,576,939 | $1,465,602 | $1,369,877 | $1,369,458 |
| Gross Profit | $854,348 | $798,815 | $765,086 | $769,803 |
| % Margin | 35.1% | 35.3% | 35.8% | 36% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $424,360 | $395,120 | $358,727 | $366,727 |
| SG&A Expenses | $424,360 | $395,120 | $358,727 | $366,727 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $63,495 | $63,126 | $62,863 | $60,038 |
| Operating Expenses | $487,855 | $458,246 | $421,590 | $426,765 |
| Operating Income | $366,493 | $340,569 | $343,496 | $343,038 |
| % Margin | 15.1% | 15% | 16.1% | 16% |
| Other Income/Exp. Net | $32,972 | $9,798 | -$13,817 | $7,276 |
| Pre-Tax Income | $399,465 | $350,367 | $329,679 | $350,314 |
| Tax Expense | $97,466 | $77,858 | $80,055 | $81,764 |
| Net Income | $301,999 | $272,509 | $249,624 | $268,550 |
| % Margin | 12.4% | 12% | 11.7% | 12.6% |
| EPS | 20.1 | 18.11 | 16.72 | 17.14 |
| % Growth | 11% | 8.3% | -2.5% | – |
| EPS Diluted | 19.89 | 17.93 | 16.53 | 16.85 |
| Weighted Avg Shares Out | 15,024 | 15,050 | 14,929 | 15,671 |
| Weighted Avg Shares Out Dil | 15,186 | 15,200 | 15,099 | 15,938 |
| Supplemental Information | – | – | – | – |
| Interest Income | $14,610 | $6,270 | $355 | $377 |
| Interest Expense | $1,780 | $3,108 | $4,584 | $1,868 |
| Depreciation & Amortization | $63,049 | $60,865 | $59,172 | $59,051 |
| EBITDA | $464,294 | $414,340 | $393,435 | $411,233 |
| % Margin | 19.1% | 18.3% | 18.4% | 19.2% |